首页>
外国专利>
MICRORNA THAT CAN BE USED FOR TREATING ARRHYTHMOGENIC CHANNELOPATHIES
MICRORNA THAT CAN BE USED FOR TREATING ARRHYTHMOGENIC CHANNELOPATHIES
展开▼
机译:微小RNA,可用于治疗心律失常性软骨病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention proposes the use of hsa-mir-219-5ρ microRNA, of SEQ ID NO: 1, of the modified polynucleotides derived therefrom, SEQ ID NO: 3 or SEQ ID NO: 5, or of the precursors thereof, SEQ ID NO: 2, SEQ ID NO: 4 or SEQ ID NO: 6, for producing drugs that can be used to treat arrhythmogenic channelopathies, preferably those caused by changes in cardiac sodium channel function, more preferably long QT syndrome type 3 and Brugada syndrome. These polynucleotides are capable of modulating cardiac sodium channel function by means of the binding thereof to the mRNA of the SCN5A gene.
展开▼
机译:本发明提出了hsa-mir-219-5ρmicroRNA,SEQ ID NO:1,其衍生的修饰多核苷酸,SEQ ID NO:3或SEQ ID NO:5或其前体的用途。 NO:2,SEQ ID NO:4或SEQ ID NO:6,用于产生可用于治疗心律失常性通道病的药物,这些药物优选是由心脏钠通道功能改变所引起的那些,更优选地是长QT综合征3型和Brugada综合征。这些多核苷酸通过与SCN5A基因的mRNA结合而能够调节心脏钠通道功能。
展开▼